Wealthy China ravenous for Danish food products

Elsewhere, medical device firm Acarix nets million kroner investment from Puhua Jingxin

China’s growing middle class has developed a penchant for Danish food products, according to the latest export figures from the Danish agriculture and food council, Landbrug & Fødevarer.

Last year, Danish food products were sold to China and Hong Kong to the tune of 10 billion kroner, and this year the exports were as high as 8.8 billion kroner for the first six months of 2016.

“Firstly, there is a growing group of well-to-do Chinese people who can afford quality food products and to travel abroad where they become inspired by food from other parts of the world,” said Michael Stahlschmidt, a consultant for issues regarding trade policy and market access at Landbrug & Fødevarer.

“Secondly, Denmark and Danish food has a strong brand in China.”

The brand is expected to be further bolstered this week when a delegation consisting of 12 Danish companies takes part in China’s biggest food fair, the ‘Food and Hotel China’ fair in Shanghai on November 9.

The Danish participants in Shanghai will be 3-Star from Horsens, Amanda Seafoods from Frederikshavn, Danpo from Give, ESS-FOOD from Brøndby, Fynbo Foods from Vrå, Jacobsens Bakery from Hedensted, Mille Baby from Store Heddinge, Royal Greenland from Svenstrup, Scandic Food from Vejle, Skovlyst Production from Farum, Tulip Food Company from Randers, and Tylstrup Kager  – Danish Speciality Foods from Støvring.

READ MORE: Funen brewery caps epic China deal

No Jingxin this one
In related news, the Chinese strategic investor Puhua Jingxin has decided to invest a double-digit million kroner amount into the Danish medical device firm Acarix.

“Following the successful completion of a further validation study, we were already on track for reimbursement applications and commercial launch in Q2 2017,” said Søren Rysholt Christiansen, the CEO of Acarix.

“We are delighted to partner with Puhua Jingxin – a joint healthcare fund aligning strategic resources from Puhua Healthcare and major pharmaceutical company Zhejiang Jingxin Pharmaceuticals. This new investment will enable us to ramp up both production and our sales organization.”

The company was founded in 2009 as a spinout from the pharma giant Coloplast.




  • Danish Intelligence Service: Threat from Russia has intensified

    Danish Intelligence Service: Threat from Russia has intensified

    In the internal Danish waters, Russia will be able to attack underwater infrastructure from all types of vessels. The target could be cables with data, electricity and gas, assesses the Danish Defense Intelligence Service

  • Denmark to explore screening citizenship applicants for anti-democratic sentiments

    Denmark to explore screening citizenship applicants for anti-democratic sentiments

    A few weeks after Alex Vanopslagh’s comments about “right values,” the government announced that an expert committee would be established to examine the feasibility of screening citizenship applicants for anti-democratic attitudes.

  • The Future Copenhagen

    The Future Copenhagen

    The municipality plan encompasses building 40,000 houses by 2036 in order to help drive real estate prices down. But this is not the only huge project that will change the shape of the city: Lynetteholmen, M5 metro line, the Eastern Ring Road, and Jernbanebyen will transform Copenhagen into something different from what we know today

  • It’s not you: winter depression is affecting many people

    It’s not you: winter depression is affecting many people

    Many people in Denmark are facing hard times marked by sadness, anxiety, and apathy. It’s called winter depression, and it’s a widespread phenomenon during the cold months in Nordic countries.

  • Crime rates are rising, but people are safer

    Crime rates are rising, but people are safer

    Crime in Denmark is increasing for the second consecutive year, but it is more focused on property, while people appear to be safer than before. Over the past year, there were fewer incidents of violence

  • Novo Nordisk invests 8.5 billion DKK in new Odense facility

    Novo Nordisk invests 8.5 billion DKK in new Odense facility

    Despite Novo’s announcement that its growth abroad will be larger than in Denmark, the company announced this morning an 8.5 billion DKK investment for a new facility in Odense. This is the first time the company has established a new production site in Denmark this century.